Loading...

Clarity

Josef Schwan

New York

Former ELT member at Danaher/Leica Biosystems — led transformative AI and software initiatives in anatomical pathology and diagnostics. Deep in digital pathology, computational pathology, companion diagnostics, and oncology. Previously BCG Project Leader. Caltech Chemistry PhD.

$5.83/min

—
0 Calls

—

0 Reviews

—

Avg. call

M&A Change Management Acquisition Integration Business Transformation Artificial Intelligence Life Sciences Diagnostics Leading transformational change M&A execution Strategic M&A

Call me to talk about

Post-Merger Integration and M&A

Led integrations spanning $50B+ combined deal value across PE-backed and corporate environments: Governance; Integration Management Office; Pre-Close Planning; Day 1 Readiness; Investment Thesis Validation; Post-Close Execution; Revenue and Cost Synergy Capture; Org Design; Change Management

Life Sciences, Diagnostics & Anatomical Pathology

Senior Director at Leica Biosystems, global leader in anatomical pathology: Tissue Diagnostics; Histology; Immunohistochemistry; Advanced Staining; Competitive Landscape; Buying Dynamics Across Hospital Labs, Reference Labs, and Pharma

Digital Pathology, Computational Pathology & AI in Diagnostics

Led nine-figure AI and software partnership at Leica Biosystems: Digital Pathology Image Analysis; Computational Pathology for Oncology; Companion Diagnostics; Regulatory Pathways; Reimbursement Dynamics; Clinical Adoption Barriers; AI Portfolio and Ecosystem Strategy; Competitive Landscape (e.g., Roche/Ventana, Hamamatsu, Philips, Indica Labs, PathAI, Sectra, etc.)

Danaher Business System (DBS)

ELT member accountable for policy deployment and Leica Biosystems strategy function and strategy KPIs: Policy Deployment; New Product Development; Launch Excellence; Sales Enablement; GTM; Funnel Management; CVDs, TTIs & KPIs (Design, Target-Setting, and Delivery)

Answers 0
Reviews 0

Answers

Reviews

Member since March 2026